# A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

> **NCT07475572** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Alvotech Swiss AG** · enrollment: 120 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** AVT32-DRL_PB
- **BIOLOGICAL:** Keytruda

## Key facts

- **NCT ID:** NCT07475572
- **Lead sponsor:** Alvotech Swiss AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-19
- **Primary completion:** 2027-10
- **Final completion:** 2028-04-14
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07475572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07475572, "A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07475572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*